Drugs

1 in 6 people rate bad primary care as “fine”, reveals 18-country survey

HQ Team July 24, 2026: Nearly one in six people surveyed across 18 countries rated a textbook case of poor primary care, including.

Read More
Drugs

Eli Lilly just spent $3.8 billion on psychedelics. Here’s why

HQ Team July 23, 2026: Eli Lilly, the pharma company behind weight-loss blockbusters Mounjaro and Zepbound recently agreed to buy AtaiBeckley, a psychedelic.

Read More
Drugs

Health benefits hype drive FDA to review 7 peptides and their sale

HQ Team July 23, 2026: Peptides, the short chains of amino acids that serve as the building blocks of proteins, are generating significant.

Read More
Drugs Health

US measles cases hit a 35-year high at 2,295

HQ Team July 22, 2026: The United States has recorded 2,295 measles cases,  the highest total in 35 years. The raw number is.

Read More
Drugs

FDA updated drug labelling regulations guide (2026)

HQ Team July 21, 2026: Every prescription drug sold in the United States carries labelling that the FDA treats as a legal document,.

Read More
Drugs Health

Scientists map 641 new schizophrenia genes using “Social Network” for DNA

HQ Team June 24,2026: Scientists have discovered 641 previously unknown genes linked to schizophrenia, using a revolutionary method that maps how genes “talk” to.

Read More
Drugs

New procedure, GAE, halves knee pain in osteoarthritis patients

HQ Team June 23, 2026: A minimally invasive procedure that blocks the small blood vessels supplying an arthritic knee can reduce pain by.

Read More
Drugs

Who is buying India’s hospitals and what it means for its 1.4 Billion people?

HQ Team Editor’s Note: The need for this story arose out of discussions on healthcare access difficulties in the developed world. Horror stories.

Read More
Drugs

FDA approves Utebzi, first carbapenem pill for complicated UTIs

HQ Team June 17, 2026: The US Food and Drug Administration has approved Utebzi (tebipenem pivoxil), an antibiotic pill for people suffering from.

Read More
Drugs Health

Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results

HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their.

Read More